Alere Inc  

(Public, NYSE:ALR)   Watch this stock  
Find more results for NYSE:IMA
51.58
+0.22 (0.43%)
May 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 50.91 - 51.98
52 week 33.76 - 51.98
Open 51.29
Vol / Avg. 421,336.00/334,270.00
Mkt cap 4.39B
P/E     -
Div/yield     -
EPS -2.24
Shares 85.13M
Beta 1.93
Inst. own 97%
Aug 21, 2015
Alere Inc Annual Shareholders Meeting (Estimated) - 10:00AM EDT - Add to calendar
Aug 3, 2015
Q2 2015 Alere Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jun 9, 2015
Alere Inc at Goldman Sachs Healthcare Conference - 2:20PM EDT - Add to calendar
Jun 1, 2015
Alere Inc at Jefferies Global Healthcare Conference - 4:00PM EDT - Add to calendar
May 5, 2015
Q1 2015 Alere Inc Earnings Release
May 5, 2015
Q1 2015 Alere Inc Earnings Call
Mar 12, 2015
Alere Inc Corporate Analyst Meeting
Mar 4, 2015
Alere Inc at Cowen Health Care Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -1.28% -7.16%
Operating margin 4.86% 3.61%
EBITD margin - 19.16%
Return on average assets - -2.69%
Return on average equity - -13.39%
Employees 9,800 -
CDP Score - -

Address

51 Sawyer Rd Ste 200
WALTHAM, MA 02453-3448
United States - Map
+1-781-6473900 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Alere Inc. is a provider of point-of-care diagnostics and services. The Company’s portfolio includes a range of health information solutions and provides clinical decision support. The Company operates in four segments: professional diagnostics, health information solutions, consumer diagnostics, and corporate and other. The professional diagnostics segment includes a range of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions. The health information solutions segment provides integrated programs and services focused on wellness, disease and condition management, productivity enhancement and informatics. The consumer diagnostics segment consists of manufacturing operations related to its role as the manufacturer of products for SPD Swiss Precision Diagnostics (SPD).

Officers and directors

Gregg J. Powers Independent Chairman of the Board
Age: 52
Bio & Compensation  - Reuters
Namal Nawana President, Chief Executive Officer, Director
Age: 44
Bio & Compensation  - Reuters
James F. Hinrichs Chief Financial Officer, Executive Vice President
Age: 47
Bio & Compensation  - Reuters
Daniella Cramp Global President - Cardiometabolic Business Unit
Age: 41
Bio & Compensation  - Reuters
Sanjay Malkani Global President - Toxicology
Age: 45
Bio & Compensation  - Reuters
Avi Pelossof Global President - Infectious Disease Business Unit
Age: 52
Bio & Compensation  - Reuters
Ellen Chiniara Senior Vice President, General Counsel, Chief Ethics and Compliance Officer and Secretary
Age: 56
Bio & Compensation  - Reuters
John Bridgen Ph.D. Senior Vice President - Business Development
Age: 68
Bio & Compensation  - Reuters
Mark Gladwell Senior Vice President - Global Operations
Age: 40
Bio & Compensation  - Reuters
Melissa Guerdan Senior Vice President - Global Quality and Regulatory Assurance
Age: 41
Bio & Compensation  - Reuters